NCT00589875Phase 2Completed

Phase 2a Study of CAN-2409 With Standard Radiation Therapy for Malignant Glioma

Study sponsor: Candel Therapeutics, Inc. · CADL

Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.

Open ClinicalTrials.gov record CSV export · Pro

Primary completion2015-12Actual

Enrollment · participants52Actual

Source updated2024-04-03Last update listed in the registry record

Version history

Changes to this trial

Last 12 months

Pro unlocks the full available history and CSV export. View Pro features

No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.